Author/Creator: Harty, Gerard - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Harty, Gerard

1. 024 CLARITY study: efficacy outcomes among patients receiving disease-modifying therapies prior to treatment with cladribine tablets. Issue 6 (27th May 2022)

Authors:: Vermersch, Patrick; Rammohan, Kottil; Damian, Doris; Jack, Dominic; Harty, Gerard; Wong, Schiffon
Journal:: Journal of neurology, neurosurgery and psychiatry
Issue:: Volume 93:Issue 6(2022)
Page Start:: A21
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Cost-effectiveness of cladribine tablets, alemtuzumab, and natalizumab in the treatment of relapsing-remitting multiple sclerosis with high disease activity in England. (3rd July 2018)

Authors:: Hettle, Robert; Harty, Gerard; Wong, Schiffon L.
Journal:: Journal of medical economics
Issue:: Volume 21:Number 7(2018)
Page Start:: 676
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Efficacy of cladribine tablets in high disease activity patients with relapsing multiple sclerosis: post hoc analysis of subgroups with and without prior disease-modifying drug treatment. (4th March 2021)

Authors:: Vermersch, Patrick; Galazka, Andrew; Dangond, Fernando; Damian, Doris; Wong, Schiffon L.; Jack, Dominic; Harty, Gerard
Journal:: Current medical research and opinion
Issue:: Volume 37:Number 3(2021)
Page Start:: 459
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Estimating the comparative efficacy of cladribine tablets versus alternative disease modifying treatments in active relapsing–remitting multiple sclerosis: adjusting for patient characteristics using meta-regression and matching-adjusted indirect treatment comparison approaches. (3rd August 2019)

Authors:: Berardi, Andrea; Siddiqui, Mohd Kashif; Treharne, Catrin; Harty, Gerard; Wong, Schiffon L.
Journal:: Current medical research and opinion
Issue:: Volume 35:Number 8(2019)
Page Start:: 1371
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Summarizing Patient Preferences for the Competitive Landscape of Multiple Sclerosis Treatment Options. (February 2020)

Authors:: Jonker, Marcel F.; Donkers, Bas; Goossens, Lucas M.A.; Hoefman, Renske J.; Jabbarian, Lea J.; de Bekker-Grob, Esther W.; Versteegh, Matthijs M.; Harty, Gerard; Wong, Schiffon L.
Journal:: Medical decision making
Issue:: Volume 40:Number 2(2020)
Page Start:: 198
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Systematic literature review and network meta-analysis of cladribine tablets versus alternative disease-modifying treatments for relapsing–remitting multiple sclerosis. (3rd August 2018)

Authors:: Siddiqui, Mohd Kashif; Khurana, Inderpreet Singh; Budhia, Sangeeta; Hettle, Robert; Harty, Gerard; Wong, Schiffon L.
Journal:: Current medical research and opinion
Issue:: Volume 34:Number 8(2018)
Page Start:: 1361
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Use of rituximab in adults with relapsing–remitting multiple sclerosis: a systematic literature review. (3rd May 2020)

Authors:: Siddiqui, Mohd Kashif; Singh, Barinder; Attri, Sumeet; Veraart, Christiaan; Harty, Gerard; Wong, Schiffon L.
Journal:: Current medical research and opinion
Issue:: Volume 36:Number 5(2020)
Page Start:: 809
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗